RegisterLogin

CMI-392

CAT: 0804-HY-19205ASize: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-19205ASize:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CMI-392 is a dual 5-lipoxygenese inhibitor and platelet-activating factor (PAF) receptor antagonist with IC50s of 100 and 10 nM, respectively.
CAS Number
[193739-23-0]
Product Name Alternative
LDP-392
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CMI-392.html
Solubility
10 mM in DMSO
Smiles
O=C(NCC1=CC([C@H]2O[C@H](C3=CC(OC)=C(OC)C(OC)=C3)CC2)=CC(OC)=C1OCCSC4=CC=C(Cl)C=C4)N(O)C
Molecular Formula
C31H37ClN2O8S
Molecular Weight
633.15
References & Citations
[1]Cai X, et al. (+/-) -trans-2-[3-methoxy-4- (4-chlorophenylthioethoxy) -5- (N-methyl-N- hydroxyureidyl) methylphenyl]-5- (3,4, 5-trimethoxyphenyl) tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist. J Med Chem. 1998 May 21;41 (11) :1970-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
5-LOX

Related Products

CatalogName
HY-105664SN 392
HY-129641KF-392
HY-W886321CRBN ligand-392
HY-RI00892A-01Hsa-miR-3929 antagomir
HY-RI00892-01Hsa-miR-3929 inhibitor
HY-R00880-01Hsa-miR-3921 mimic
HY-RI00883-01Hsa-miR-3923 inhibitor
HY-RI00880A-01Hsa-miR-3921 antagomir
HY-R00892A-01Hsa-miR-3929 agomir
HY-R00884-01Hsa-miR-3924 mimic

Alternative Products

CatalogName
MBS5766380CMI-392
MBS5775300KF 392
MBS5779335AG 392
B2189-5KX-392 dihydrochloride
sc-81956Barx1 (392.8)
MBS7153590Rabbit anti-Escherichia coli cmi Polyclonal Antibody
MBS8509488-01p53 (Ab-392) Antibody
E11-0075BKSR (Ab-392) Antibody
053-18Chromogranin A (392-402) (Mouse)
MBS1131182-01Recombinant Escherichia coli Colicin-M immunity protein (cmi)

Popular Products